MarketPeel
Insider Trading Intelligence
HS

Harold H. Shlevin

GALT
CHIEF EXECUTIVE OFFICER · GALECTIN THERAPEUTICS INC · CIK 0001557082
FILING MIX · LIFETIME43%/57%
BUYS
20
SELLS
26
TOTAL VALUE
$2.15M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
28,768
AVG SELL PX
$6.02
TRADE KIND
SHOWING 46 / 46
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 23 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Harold H. Shlevin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+41.67%-6.84%+0.34%-7.18%+7.77%
14d12+100.00%-31.18%+0.50%-31.69%-33.23%
30d12+100.00%-40.91%+1.49%-42.40%-42.07%
60d12+100.00%-46.60%+1.08%-47.68%-54.51%
90d12+100.00%-41.84%-1.19%-40.65%-43.57%
180d12+100.00%-46.62%+8.17%-54.79%-68.83%
1y12(11 pending)+100.00%+270.91%+17.15%+253.76%+253.76%
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GALT · 28,768 shares · as of Jun 29, 2026
018,30336,60554,90873,210202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 26 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
22,268$1.23$27.4K28,768Jun 29, 2026Jun 30, 2026View →
GALT
GALECTIN THERAPEUTICS INC
SALE
22,26830,000Jun 29, 2026Jun 30, 2026View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
22,268$5.04$112.2K6,500Jun 29, 2026Jun 30, 2026View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
7,732$1.23$9.5K14,232Jun 26, 2026Jun 30, 2026View →
GALT
GALECTIN THERAPEUTICS INC
SALE
7,73252,268Jun 26, 2026Jun 30, 2026View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
7,732$5.00$38.7K6,500Jun 26, 2026Jun 30, 2026View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
60,00060,000Jan 16, 2026Jan 21, 2026View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
4,706$7.04$33.1K6,500Dec 17, 2025Dec 19, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
20,0000Dec 17, 2025Dec 19, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
20,000$1.98$39.6K31,206Dec 17, 2025Dec 19, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
19,793$7.04$139.3K11,206Dec 17, 2025Dec 19, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
8,4170Dec 15, 2025Dec 16, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
8,417$4.16$35.0K19,623Dec 15, 2025Dec 16, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
8,417$6.30$53.0K11,206Dec 15, 2025Dec 16, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
19,79353,417Dec 12, 2025Dec 16, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
19,793$4.16$82.3K30,999Dec 12, 2025Dec 16, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
19,793$6.27$124.2K11,206Dec 12, 2025Dec 16, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
16,79073,210Dec 9, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
16,790$4.16$69.8K27,996Dec 9, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
16,790$6.27$105.2K11,206Dec 9, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
35,000$2.86$100.1K46,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
25,000$5.95$148.7K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
35,000$6.02$210.7K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
20,000$5.96$119.2K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
20,000$1.98$39.6K31,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
20,000$6.00$120.0K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
35,000$5.95$208.3K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
25,00025,000Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
25,000$1.72$43.0K36,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
35,000$2.11$73.8K46,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
20,000$5.96$119.2K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
20,000$2.11$42.2K31,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
35,00035,000Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
20,000$1.11$22.2K31,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
35,00035,000Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
20,00020,000Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE10b5-1
10b5-1 plan
4,000$6.01$24.0K11,206Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
20,00020,000Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
SALE
20,00020,000Dec 8, 2025Dec 10, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
60,00060,000Jan 23, 2025Jan 30, 2025View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASE
6,500$1.16$7.5K15,206Dec 30, 2024Dec 31, 2024View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Jan 26, 2023Jan 30, 2023View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Jan 24, 2022Jan 25, 2022View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Mar 25, 2021Mar 29, 2021View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
70,00070,000Mar 25, 2021Mar 29, 2021View →
GALT
GALECTIN THERAPEUTICS INC
PURCHASEGRANT
Stock grant
70,00070,000Jan 9, 2020Jan 13, 2020View →
Other insiders · GALT
Loading peer insiders…
About this filer
CIK 0001557082
ROLE
Chief Executive Officer
PRIMARY
GALT
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001557082DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback